|
- 2019
Safety and efficacy of miltefosine in cutaneous leishmaniasis: An open label, non-comparative study from BalochistanKeywords: Cutaneous leishmaniasis, Meglumine antimoniate, Miltefosine Abstract: Cutaneous Leishmaniasis (CL) is endemic in Baluchistan and treated traditionally with Meglumine antimoniate. Miltefosine appears appealing therapy in cutaneous Leishmaniasis. Our objective was to evaluate safety and efficacy of Miltifossine in treatment of cutaneous Leishmaniasis
|